Viral clearance is critical in the development of monoclonal antibodies, recombinant proteins and
glycoproteins,
tissue and blood-derived products and medical devices. Viral contamination usually comes from the use of
cell
lines, tissue sources or raw materials of animal origin. The ICH Q5A Regulatory Guidelines recommend that
biopharmaceutical products for human use should ensure that their products' safety is not affected by
potential contaminants.
Creative Biolabs offers a comprehensive, fully cGMP-compliant virus clearance service that
spans all stages of
the development, manufacture and release of biological products. Our virus clearance team has conducted
thousands of tests for biopharmaceutical customers, all of which have been fully validated and followed ICH
Q2
requirements.
Process Steps for Virus Clearance
Virus Inactivation
-
Organic Solvent
-
Detergent
-
Caprylate
-
Chaotropes
-
Low pH
-
High pH
-
Enzymes
-
Dry Heat
-
Pasteurization
-
Vapor Heating
-
High Temperature Short Time
-
Photo Inactivation
-
UV with Photoactive Compounds
-
Gamma Irradiation
-
Microwave
Virus Removal
-
Chromatography
-
Affinity
-
Ion Exchange
-
Hydrophobic
-
Gel Filtration
-
Nanofiltration
We offer virus clearance services for a variety of viruses to help you submit regulatory requests,
including:
-
Adenovirus clearance
-
Retroviral clearance
-
Parvovirus clearance
-
Pseudorabies virus clearance
-
Influenza virus clearance
-
More…
Examples of products for virus clearance studies:
-
Monoclonal antibodies
-
Recombinant proteins
-
Blood-derived products
-
Gene therapy vectors
-
Viral vaccines Tissues
-
Urine-derived products
-
Tissue-derived products
-
Medical devices (including collagen-derived products)
-
Enzymes
With years of experience and a GMP-qualified laboratory, Creative Biolabs’ viral clearance services ensure
that your biological production process complies with international guidelines.
For more details, please feel free to contact us for project quotations and more minute information.